Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › AUBURN › SUTTER VALLEY HOSPITALS

SUTTER VALLEY HOSPITALS

NPI: 1194774299 · AUBURN, CA 95602 · General Acute Care Hospital · NPI assigned 05/08/2006

$15.54M
Total Medicaid Paid
266,223
Total Claims
227,947
Beneficiaries
131
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCONFORTI, JAMES (PRESIDENT/CEO)
Parent OrganizationSUTTER VALLEY HOSPITALS
NPI Enumeration Date05/08/2006

Related Entities

Other providers sharing the same authorized official: CONFORTI, JAMES

ProviderCityStateTotal Paid
SUTTER VALLEY HOSPITALS ROSEVILLE CA $81.16M
SUTTER VALLEY HOSPITALS VALLEJO CA $33.28M
SUTTER VALLEY HOSPITALS DAVIS CA $20.04M
SUTTER VALLEY HOSPITALS JACKSON CA $11.20M
SUTTER VALLEY HOSPITALS SACRAMENTO CA $3.16M
SUTTER VALLEY HOSPITALS AUBURN CA $165K
SUTTER VALLEY HOSPITALS AUBURN CA $25K
SUTTER VALLEY HOSPITALS SACRAMENTO CA $71.31
SUTTER VALLEY HOSPITALS ROSEVILLE CA $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 38,655 $2.16M
2019 36,101 $1.94M
2020 26,780 $1.34M
2021 36,515 $2.30M
2022 40,541 $2.48M
2023 49,820 $2.88M
2024 37,811 $2.43M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
0450 Emergency room services 28,520 25,193 $2.91M
99199 Unlisted special service, procedure or report 15,519 13,402 $1.84M
99281 Emergency department visit for the evaluation and management, self-limited or minor 7,118 6,237 $938K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7,701 7,029 $806K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,751 1,693 $701K
70450 Computed tomography, head or brain; without contrast material 1,938 1,864 $568K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1,966 1,921 $441K
0250 8,917 4,133 $432K
96375 Therapeutic injection; each additional sequential IV push 5,942 5,191 $429K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,665 3,361 $419K
80053 Comprehensive metabolic panel 13,784 12,427 $408K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,710 4,522 $379K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 6,062 5,701 $296K
82077 2,152 1,934 $285K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,106 1,760 $267K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 18,648 16,416 $247K
J3490 Unclassified drugs 11,720 6,570 $236K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" 6,059 2,997 $206K
74176 Computed tomography, abdomen and pelvis; without contrast material 962 928 $193K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,964 3,422 $182K
71046 Radiologic examination, chest; 2 views 3,931 3,796 $181K
Z7502 4,681 4,585 $177K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,167 2,709 $168K
80143 1,319 1,213 $166K
96361 Intravenous infusion, hydration; each additional hour 3,341 3,007 $158K
80179 1,285 1,196 $157K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,150 1,123 $134K
71045 Radiologic examination, chest; single view 4,424 4,124 $119K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,043 982 $108K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 400 218 $108K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,207 1,185 $99K
80048 Basic metabolic panel (calcium, ionized) 3,858 3,621 $94K
96376 388 318 $94K
J7030 Infusion, normal saline solution , 1000 cc 7,094 6,330 $91K
99283 Emergency department visit for the evaluation and management, moderate severity 1,372 1,167 $83K
84484 4,622 3,675 $76K
83690 5,159 4,785 $63K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 269 268 $61K
J2405 Injection, ondansetron hydrochloride, per 1 mg 5,104 4,503 $54K
73610 916 884 $51K
87040 2,220 1,385 $50K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 885 868 $48K
73630 931 896 $48K
87086 Culture, bacterial; quantitative colony count, urine 3,796 3,614 $46K
83880 1,093 988 $46K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,268 4,013 $44K
81001 6,303 5,943 $41K
0270 998 481 $38K
81025 3,497 3,374 $35K
83735 2,793 2,478 $32K
73110 577 530 $31K
83605 1,742 1,432 $30K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 809 486 $30K
73562 615 597 $29K
J1170 Injection, hydromorphone, up to 4 mg 1,980 1,627 $29K
76705 Ultrasound, abdominal, real time with image documentation; limited 242 233 $28K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 699 613 $27K
82803 983 899 $26K
72125 Computed tomography, cervical spine; without contrast material 50 49 $25K
73030 471 449 $25K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 340 336 $24K
81003 3,886 3,742 $23K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 324 320 $22K
84443 Thyroid stimulating hormone (TSH) 753 731 $21K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,569 1,385 $21K
71260 Computed tomography, thorax, diagnostic; with contrast material 41 39 $20K
90715 273 272 $19K
73130 306 293 $18K
99284 Emergency department visit for the evaluation and management, high severity 235 225 $18K
82330 690 585 $15K
71275 Computed tomographic angiography, chest, with contrast material 56 54 $15K
J7120 Ringers lactate infusion, up to 1000 cc 1,085 959 $13K
87634 111 110 $11K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 467 465 $11K
87077 1,109 1,007 $11K
J2060 Injection, lorazepam, 2 mg 1,014 863 $10K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 70 70 $10K
87186 1,106 1,031 $10K
71250 53 52 $10K
85610 1,594 1,464 $10K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 61 60 $9K
93971 30 30 $8K
85379 371 363 $7K
87430 370 367 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg 682 609 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 507 487 $6K
76830 Ultrasound, transvaginal 26 26 $5K
87400 427 419 $5K
J2270 Injection, morphine sulfate, up to 10 mg 333 281 $5K
87081 347 341 $5K
82947 669 543 $5K
84702 341 316 $3K
73502 56 51 $3K
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 110 69 $3K
85730 267 256 $2K
0510 277 194 $2K
J3010 Injection, fentanyl citrate, 0.1 mg 235 230 $2K
J7050 Infusion, normal saline solution, 250 cc 138 118 $2K
73140 27 26 $1K
84132 325 287 $917.80
84295 299 267 $871.62
J2765 Injection, metoclopramide hcl, up to 10 mg 72 65 $712.53
87070 42 41 $664.43
72100 12 12 $642.45
J2250 Injection, midazolam hydrochloride, per 1 mg 73 72 $526.90
J0780 Injection, prochlorperazine, up to 10 mg 16 13 $517.76
J2919 Injection, methylprednisolone sodium succinate, 5 mg 14 12 $477.06
84703 331 324 $466.67
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 38 38 $349.03
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 13 13 $311.34
86900 59 36 $302.13
86901 53 37 $291.72
87147 21 12 $256.75
S0028 Injection, famotidine, 20 mg 12 12 $230.35
99282 Emergency department visit for the evaluation and management, low to moderate severity 12 12 $205.58
87420 14 14 $200.98
0761 13 12 $190.16
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 171 168 $165.95
J2704 Injection, propofol, 10 mg 26 24 $165.03
J3475 Injection, magnesium sulfate, per 500 mg 13 12 $151.83
86308 15 14 $140.23
87205 15 14 $136.35
J2550 Injection, promethazine hcl, up to 50 mg 14 12 $119.38
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 19 18 $107.04
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 39 37 $80.02
J2470 Injection, pantoprazole sodium, 40 mg 13 13 $50.19
85652 14 14 $49.73
86140 12 12 $47.08
36415 Collection of venous blood by venipuncture 19 12 $5.88
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 52 46 $2.34
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 140 138 $1.62